Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: An open multicentre study

British Journal of Dermatology

Volumn 137, Issue 2, 1997, Pages 251-254

  Gupta, A K ^a,h   Alexis, M E ^b   Raboobee, N ^c   Hofstader, S L R ^d   Lynde, C W ^e   Adam, P ^f   Summerbell, R C ^b   De Doncker, P ^g  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KING EDWARD VIII HOSPITAL   (South Africa)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g JANSSEN RESEARCH FOUNDATION   (Belgium)

^h NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MICROSPORUM GYPSEUM; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TINEA CAPITIS; TRICHOPHYTON;

EID: 0030801411     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1997.18141912.x     Document Type: Article

References (23)

1. Franks AG, Taschdjian CL. Incidence and etiology of tinea capitis. Arch Dermatol 1956; 74: 348-51.
2. Korstanje MJ, Staats CCG. Tinea capitis in Northwestern Europe 1963-1993: Etiologic agents and their changing prevalence. Int J Dermatol 1994; 33: 548-9.
3. Frieden IJ. Diagnosis and management of tinea capitis. Pediatr Ann 1987; 16: 39-48.
4. Kovacs MJ, Alshammari S, Guenther L et al. Neutropenia and pancytopenia associated with oral terbinafine. J Am Acad Dermatol 1994; 31: 806.
5. Health Protection Branch HC. Canadian adverse drug reaction newsletter: terbinafine - hematological disorders. Clin Med Assoc J 1994; 151: 64-5.
6. Krowchuk DP, Lucky AW, Primmer SI et al. Current status of the identification and management of tinea capitis. Pediatrics 1983; 72: 625-31.
7. Rosenthal T. Perspectives in ringworm of the scalp. Arch Dermatol 1960; 82: 53-8.
8. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part I. J Am Acad Dermatol 1994; 30: 677-98.
9. Gan VN, Petruska M, Ginsburg CM. Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin. Pediatr Infect Dis J 1987; 6: 46-9.
10. Tanz RR, Herbert AA, Burton Esterly N. Treating tinea capitis. Should ketoconazole replace griscofulvin? J Pediatr 1988; 112: 987-91.
11. Degreef H. Itraconazole in the treatment of tinea capitis. Cutis 1996; 58: 90-3.
12. Legendre R, Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol 1990; 23: 559-60.
13. Elewski B. Tinea capitis: itraconazole in Trichophyton tonsurans infection. J Am Acad Dermatol 1994; 31: 65-7.
14. López-Gómez S, Del Palacio A, Van Cutsem J et al. Itraconazole vs. griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol 1994; 33: 743-7.
15. Greer DL. Treatment of tinea capitis with itraconazole. J Am Acad Dermatol 1996; 35 (4): 637-8.
16. Jones TC. Overview of the use of terbinafine (Lamisil®) in children. Br J Dermatol 1995; 132: 683-9.
17. Haroon TS, Hussain I, Mahmood A et al. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol 1992; 126: 47-50.
18. Nejjam F, Zagula M, Cabiac MD et al. Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol 1995; 132: 98-105.
19. del Carmen Padilla Desgarennes M, Godoy MR, Palencia AB. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans. J Am Acad Dermatol 1996; 35: 114-16.
20. Haroon TS, Hussain I, Aman S et al. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br J Dermatol 1995; 135: 86-8.
21. Cauwenbergh G, Degreef H, Heykants J et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263-8.
22. Van Cutsem J, Van Gerven F. Therapeutic oral treatment with itraconazole oral solution of experimental microsporosis in cats. Efficacy and hair antifungal levels. A dose-titration study. Janssen Research Foundation. Report N 85581/1. 1991: 1-7.
23. Gupta AK, Sibbald RG, Lynde CW et al. The prevalence of onychomycosis in children and treatment strategies. J Am Acad Dermatol 1997; 36: 395-402.